Advances in Colorectal Cancer Detection: Exploring the Role of Blood-Based Tests

Host: Peter Buch, MD, FACG, AGAF, FACP Guest: Aasma Shaukat, MD, MPH Blood-based colorectal cancer screening is entering a new era with FDA-approved and emerging tests like Shield and Simple Screen. Alongside updated stool-based options such as Cologuard Plus and CRC-PREVENT, clinicians now have a broader landscape of noninvasive tools to consider and discuss with their patients. Joining Dr. Peter Buch to talk about current recommendations and potential future directions for colorectal cancer screening is Dr. Aasma Shaukat. Dr. Shaukat is the Robert M. and Mary H. Glickman Professor of Medicine and a Professor of Population Health at NYU Grossman School of Medicine, as well as the Director of Outcomes Research in the Division of Gastroenterology and Hepatology at NYU Langone Health. She's also a co-author of a recent review on blood tests for colorectal cancer.

You can listen to Advances in Colorectal Cancer Detection: Exploring the Role of Blood-Based Tests online on Radio and Podcast. Open the player on this page to stream the available audio.

Advances in Colorectal Cancer Detection: Exploring the Role of Blood-Based Tests is an episode from GI Insights by ReachMD.

This episode is 00:13:30 long.

This episode was published on Nov 24, 2025.

Yes. Use the heart button on the episode page to add it to your favorite episodes list.

Yes. This page shows related episodes from GI Insights when more episodes are available from the podcast feed.